These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19125350)

  • 1. Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy.
    Pierre G; Setchell K; Blyth J; Preece MA; Chakrapani A; McKiernan P
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S241-5. PubMed ID: 19125350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Neonatal Cholestasis in Cerebrotendinous Xanthomatosis: Genetics, Immunostaining, Mass Spectrometry.
    Gong JY; Setchell KDR; Zhao J; Zhang W; Wolfe B; Lu Y; Lackner K; Knisely AS; Wang NL; Hao CZ; Zhang MH; Wang JS
    J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):561-568. PubMed ID: 28937538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.
    Keren Z; Falik-Zaccai TC
    Pediatr Endocrinol Rev; 2009 Sep; 7(1):6-11. PubMed ID: 19696711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults.
    Mandia D; Chaussenot A; Besson G; Lamari F; Castelnovo G; Curot J; Duval F; Giral P; Lecerf JM; Roland D; Pierdet H; Douillard C; Nadjar Y
    J Neurol; 2019 Aug; 266(8):2043-2050. PubMed ID: 31115677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in an infant with cerebrotendinous xanthomatosis, cholestasis, and rapid evolution of liver failure.
    Pietrobattista A; Spada M; Candusso M; Boenzi S; Dionisi-Vici C; Francalanci P; Morrone A; Ferri L; Indolfi G; Agolini E; Giordano G; Monti L; Maggiore G; Knisely AS
    Pediatr Transplant; 2022 Sep; 26(6):e14318. PubMed ID: 35633129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebrotendinous xanthomatosis: physiopathology, clinical manifestations and genetics].
    Preiss Y; Santos JL; Smalley SV; Maiz A
    Rev Med Chil; 2014 May; 142(5):616-22. PubMed ID: 25427019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis.
    Clayton PT; Verrips A; Sistermans E; Mann A; Mieli-Vergani G; Wevers R
    J Inherit Metab Dis; 2002 Oct; 25(6):501-13. PubMed ID: 12555943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
    Heller R; Grau AJ; Schäbitz WR; Schwaninger M
    Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrotendinous xanthomatosis: a treatable hereditary neuro-metabolic disease.
    Cerqueira AC; Nardi AE; Bezerra JM
    Clinics (Sao Paulo); 2010; 65(11):1217-8. PubMed ID: 21243300
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.
    Nie S; Chen G; Cao X; Zhang Y
    Orphanet J Rare Dis; 2014 Nov; 9():179. PubMed ID: 25424010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment.
    Huidekoper HH; Vaz FM; Verrips A; Bosch AM
    Eur J Pediatr; 2016 Jan; 175(1):143-6. PubMed ID: 26156051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).
    Salen G; Steiner RD
    J Inherit Metab Dis; 2017 Nov; 40(6):771-781. PubMed ID: 28980151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and follow-up of children with cerebrotendinous xanthomatosis.
    van Heijst AF; Verrips A; Wevers RA; Cruysberg JR; Renier WO; Tolboom JJ
    Eur J Pediatr; 1998 Apr; 157(4):313-6. PubMed ID: 9578968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.
    Wong JC; Walsh K; Hayden D; Eichler FS
    J Inherit Metab Dis; 2018 Jul; 41(4):647-656. PubMed ID: 29484516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy.
    von Bahr S; Björkhem I; Van't Hooft F; Alvelius G; Nemeth A; Sjövall J; Fischler B
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):481-6. PubMed ID: 15795599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cerebrotendinous xanthomatosis in pregnancy: Patient and physician perspectives.
    Duell PB; Dutta R; Wolf A; Rosengrant H
    J Clin Lipidol; 2023; 17(5):700-703. PubMed ID: 37543441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset epilepsy as the main neurological manifestation of cerebrotendinous xanthomatosis.
    Pedroso JL; Pinto WB; Souza PV; Santos LT; Abud IC; Avelino MA; Barsottini OG
    Epilepsy Behav; 2012 Jul; 24(3):380-1. PubMed ID: 22658436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrotendinous xanthomatosis in three siblings from a Chinese family.
    Ko KF; Lee KW
    Singapore Med J; 2001 Jan; 42(1):30-2. PubMed ID: 11361235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrotendinous xanthomatosis.
    Bel S; García-Patos V; Rodríguez L; Selva A; Díaz P; Wolthers BG; Castells A
    J Am Acad Dermatol; 2001 Aug; 45(2):292-5. PubMed ID: 11464194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A newborn screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios.
    Vaz FM; Bootsma AH; Kulik W; Verrips A; Wevers RA; Schielen PC; DeBarber AE; Huidekoper HH
    J Lipid Res; 2017 May; 58(5):1002-1007. PubMed ID: 28314860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.